'Highly contagious' and drug-resistant ringworm infections found in New York City
The first U.S. cases of a drug-resistant ringworm have been discovered in New York City, according to a report from the Centers for Disease Control and Prevention (CDC).
Ringworm is "a common, highly contagious, superficial infection of the skin, hair, or nails" caused by a fungus known as Trichophyton indotineae. It spreads via skin-to-skin contact and "usually looks like a circular pattern of raised, itchy scales," according to NBC News.
There have been two reported cases in two unrelated women. One of the women had no history of international travel, meaning the spread came from within the U.S., CNN reports. Cases first appeared in South Asia before popping up in Europe and now the U.S. The CDC believes that the fungus' new-found drug resistance is due to the "misuse and overuse of topical antifungals and corticosteroids."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"It may also be a little more widespread than we have noted before," Dr. Priya Soni of Cedars-Sinai Medical Center told CNN. "I think it's important to be aware that we may be seeing more of this particular species as we go into the warmer, moist summer months." Other fungal infections, like Candida auris, have also begun to make an appearance, likely because of climate change. "Any kind of ringworm really flourishes in the warm, moist weather," Soni continued. "I think with globalization and just the travel that we're going to see over the summer, this may be something that we may see more of as the months go on."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
'A direct, protracted war with Israel is not something Iran is equipped to fight'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Today's political cartoons - April 17, 2024
Cartoons Wednesday's cartoons - political anxiety, jury sorting hat, and more
By The Week US Published
-
Arid Gulf states hit with year's worth of rain
Speed Read The historic flooding in Dubai is tied to climate change
By Peter Weber, The Week US Published
-
Lead poisoning remains a threat
The Explainer The toxin is built into our lives
By Devika Rao, The Week US Published
-
The best health care systems in the world
In the spotlight Getting sick has never felt better
By Devika Rao, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published